Epigenetic mechanisms could be involved in CCL2 repression in neuroblastoma, as recently described in lung cancer, where epigenetic silencing of CCL2 by DNMT1 and the EZH2/H3K27me3 axis potentiates tumor development by inhibiting macrophage infiltration (44). The gene discussed is DNMT1; the disease is neuroblastoma.